Voriconazole plus flucytosine is not superior to amphotericin B deoxycholate plus flucytosine as an induction regimen for cryptococcal meningitis treatment.
Handan ZhaoYanqiu LuShan LiJiangying QinMiaomiao XuHui YeZongxing YangJianfeng RaoGuochun ChenFeifei SuZhiliang HuLijun XuPublished in: Mycoses (2023)
The Vori + 5-FC regimen was associated with low 2-week CSF sterile culture and was not superior to AmBd + 5-FC as induction therapy in terms of the 90-day cumulative survival rate of CM patients.